Jump to ContentJump to Main Navigation
Show Summary Details
Weitere Optionen …

Journal of Pediatric Endocrinology and Metabolism

Editor-in-Chief: Kiess, Wieland

Hrsg. v. Bereket, Abdullah / Darendeliler, Feyza / Dattani, Mehul / Gustafsson, Jan / Luo, Fei Hong / Mericq, Veronica / Toppari, Jorma


IMPACT FACTOR 2018: 1.239

CiteScore 2018: 1.22

SCImago Journal Rank (SJR) 2018: 0.507
Source Normalized Impact per Paper (SNIP) 2018: 0.562

Print
ISSN
0334-018X
Alle Formate und Preise
Weitere Optionen …
Band 29, Heft 5

Hefte

Novel AVPR2 mutation causing partial nephrogenic diabetes insipidus in a Japanese family

Sumie Yamashita / Astuko Hata
  • Kitano Hospital Tazuke Kofukai Medical Research Institute, Department of Pediatrics, Osaka, Japan
  • Weitere Artikel des Autors:
  • De Gruyter OnlineGoogle Scholar
/ Takeshi Usui
  • Clinical Research Institute for Endocrine and Metabolic Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
  • Weitere Artikel des Autors:
  • De Gruyter OnlineGoogle Scholar
/ Hirotsugu Oda
  • Kitano Hospital Tazuke Kofukai Medical Research Institute, Department of Pediatrics, Osaka, Japan
  • Weitere Artikel des Autors:
  • De Gruyter OnlineGoogle Scholar
/ Atsushi Hijikata / Tsuyoshi Shirai / Naoto Kaneko
  • Department of Pediatric Nephrology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan
  • Weitere Artikel des Autors:
  • De Gruyter OnlineGoogle Scholar
/ Daisuke Hata
  • Kitano Hospital Tazuke Kofukai Medical Research Institute, Department of Pediatrics, Osaka, Japan
  • Weitere Artikel des Autors:
  • De Gruyter OnlineGoogle Scholar
Online erschienen: 12.03.2016 | DOI: https://doi.org/10.1515/jpem-2015-0323

Abstract

Background: X-linked recessive congenital nephrogenic diabetes insipidus (NDI) is caused by mutations of the arginine vasopressin type 2 receptor gene (AVPR2). More than 200 mutations of the AVPR2 gene with complete NDI have been reported although only 15 mutations with partial NDI has been reported to date.

Methods: We herein report a Japanese kindred with partial NDI. The proband is an 8-year-old boy who was referred to our hospital for nocturnal enuresis. Water deprivation test and hypertonic saline test suggested partial renal antidiuretic hormone arginine vasopressin (AVP) resistance.

Results: Analysis of genomic DNA revealed a novel missense mutation (p.L161P) in the patient. The patient’s mother was heterozygous for the mutation. Three-dimensional (3-D) modeling study showed that L161P possibly destabilizes the transmembrane domain of the V2 receptor, resulting in its misfolding or mislocalization.

Conclusions: Distinguishing partial NDI from nocturnal enuresis is important. A clinical clue for diagnosis of partial NDI is an incompatibly high level of AVP despite normal serum osmolality.

Keywords: AVPR2; nocturnal enuresis; partial nephrogenic diabetes insipidus

References

  • 1.

    Birnbaumer M, Seibold A, Gilbert S, Ishido M, Barberis C, et al. Molecular cloning of the receptor for human antidiuretic hormone. Nature 1992;357:333–5.Google Scholar

  • 2.

    Deen PM, Verdijk MA, Knoers NV, Wieringa B, Monnens LA, et al. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 1994;264:92–5.Google Scholar

  • 3.

    Spanakis E, Milord E, Gragnoli C. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance. J Cell Physiol 2008;217:605–17.Web of ScienceGoogle Scholar

  • 4.

    Fujimoto M, Okada S, Kawashima Y, Nishimura R, Miyahara N, et al. Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan. Yonago Acta Med 2014;57:85–91.Google Scholar

  • 5.

    Sadeghi H, Robertson GL, Bichet DG, Innamorati G, Birnbaumer M. Biochemical basis of partial nephrogenic diabetes insipidus phenotypes. Mol Endocrinol 1997;11:1806–13.Google Scholar

  • 6.

    Bockenhauer D, Carpentier E, Rochdi D, van’t Hoff W, Breton B, et al. Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus. Nephron Physiol 2010;114:1–10.Google Scholar

  • 7.

    Inaba S, Hatakeyama H, Taniguchi N, Miyamori I. The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus. J Clin Endocrinol Metab 2001;86:381–5.Google Scholar

  • 8.

    Chen CH, Chen WY, Liu HL, Liu TT, Tsou AP, et al. Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients. J Hum Genet 2002;47:66–73.Google Scholar

  • 9.

    Takahashi K, Makita N, Manaka K, Hisano M, Akioka Y, et al. V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists. J Biol Chem 2012;287:2099–106.Web of ScienceGoogle Scholar

  • 10.

    Sahakitrungruang T, Tee MK, Rattanachartnarong N, Shotelersuk V, Suphapeetiporn K, et al. Functional characterization of vasopressin receptor 2 mutations causing partial and complete congenital nephrogenic diabetes insipidus in Thai families. Horm Res Paediatr 2010;73:349–54.Google Scholar

  • 11.

    Szalai C, Triga D, zinner A. C112R, W323S, N317K mutations in the vasopressin V2 receptor gene in patients with nephrogenic diabete. Hum Mutat 1998;12:137–8.Google Scholar

  • 12.

    Neocleous V, Skordis N, Shammas C, Efstathiou E, Mastroyiannopoulos NP, et al. Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature. Metabolism 2012;61:922–30.Google Scholar

  • 13.

    Wildin RS, Cogdell DE, Valadez V. AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus. Kidney Int 1998;54:1909–22.Google Scholar

  • 14.

    Tajima T, Nakae J, Takekoshi Y, Takahashi Y, Yuri K, et al. Three novel AVPR2 mutations in three Japanese families with X-linked nephrogenic diabetes insipidus. Pediatr Res 1996;39:522–6.Google Scholar

  • 15.

    Faerch M, Christensen JH, Corydon TJ, Kamperis K, de Zegher F, et al. Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene. Clin Endocrinol 2008;68:395–403.Google Scholar

  • 16.

    Ala Y, Morin D, Mouillac B, Sabatier N, Vargas R, et al. Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol 1998;9:1861–72.Google Scholar

  • 17.

    Robertson GL, Mahr EA, Athar S, Sinha T. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 1973;52:2340–52.Google Scholar

  • 18.

    Soding J, Biegert A, Lupas AN. The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res 2005;33:W244–8.Google Scholar

  • 19.

    Hijikata A, Yura K, Noguti T. Go M. Revisiting gap locations in amino acid sequence alignments and a proposal for a method to improve them by introducing solvent accessibility. Proteins 2011;79:1868–77.Web of ScienceGoogle Scholar

  • 20.

    Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, et al. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 2000;29:291–325.Google Scholar

  • 21.

    Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993;26:283–91.Google Scholar

  • 22.

    Nejsum LN, Christensen TM, Robben J H, Milligan G, Deen PM, et al. Novel mutation in the AVPR2 gene in a Danish male with nephrogenic diabetes insipidus caused by ER retention and subsequent lysosomal degradation of the mutant receptor. NDT Plus 2011;4:158–63.Google Scholar

  • 23.

    Fujiwara TM, Bichet DG. Molecular biology of hereditary diabetes insipidus. J Am Soc Nephrol 2005;16:2836–46.Google Scholar

  • 24.

    Hong CR, Kang HG, Choi HJ, Cho MH, Lee JW, et al. X-linked recessive nephrogenic diabetes insipidus: a clinico-genetic study. J Pediatr Endocrinol Metab 2014;27:93–9.Google Scholar

  • 25.

    Bichet DG, Birnbaumer M, Lonergan M, Arthus MF, Rosenthal W, et al. Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet 1994;55:278–86.Google Scholar

  • 26.

    Rochdi MD, Vargas GA, Carpentier E, Oligny-Longpré G, Chen S, et al. Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments. Mol Pharmacol 2010;77:836–45.Google Scholar

  • 27.

    Arthus MF, Lonergan M, Crumley MJ, Naumova AK, Morin D, et al. Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 2000;11:1044–54.Google Scholar

  • 28.

    van Lieburg AF, Knoers NV, Monnens LA. Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 1999;10:1958–64.Google Scholar

  • 29.

    Nomura Y, Onigata K, Nagashima T, Yutani S, Mochizuki H, et al. Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation. J Clin Endocrinol Metab 1997;82:3434–7.Google Scholar

  • 30.

    Giri D, Hart R, Jones C, Ellis I, Ramakrishnan R. An unusual case of hereditary nephrogenic diabetes insipidus (HNDI) affecting mother and daughter. J Pediatr Endocrinol Metab 2016;1:93–6.Web of ScienceGoogle Scholar

Artikelinformationen

Corresponding author: Sumie Yamashita, Kitano Hospital Tazuke Kofukai Medical Research Institute, Department of Pediatrics, Osaka, Japan, E-mail:


Erhalten: 15.08.2015

Angenommen: 30.12.2015

Online erschienen: 12.03.2016

Erschienen im Druck: 01.05.2016


Quellenangabe: Journal of Pediatric Endocrinology and Metabolism, Band 29, Heft 5, Seiten 591–596, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: https://doi.org/10.1515/jpem-2015-0323.

Zitat exportieren

©2016 by De Gruyter.Get Permission

Zitierende Artikel

Hier finden Sie eine Übersicht über alle Crossref-gelisteten Publikationen, in denen dieser Artikel zitiert wird. Um automatisch über neue Zitierungen dieses Artikels informiert zu werden, aktivieren Sie einfach oben auf dieser Seite den „E-Mail-Alert: Neu zitiert“.

[1]
Akihiro Kanematsu
International Neurourology Journal, 2016, Jahrgang 20, Nummer Suppl 2, Seite S105
[2]
Werner Keenswijk and Johan Vande Walle
Pediatric Nephrology, 2017, Jahrgang 32, Nummer 5, Seite 769

Kommentare (0)